Colonial Trust’s Bristol-Myers Squibb BMY Stock Holding History

Colonial Trust’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$449K	Sell	7,794 -975	-11%	-$56K	0.06%	187
2026 Q1	$532K	Sell	8,769 -30	-0.3%	-$1.75K	0.07%	176
2025 Q4	$475K	Sell	8,799 -205	-2%	-$9.86K	0.06%	191
2025 Q3	$406K	Sell	9,004 -233	-3%	-$10.9K	0.05%	214
2025 Q2	$428K	Buy	9,237 +23	+0.2%	+$1.13K	0.06%	199
2025 Q1	$562K	Sell	9,214 -803	-8%	-$46.8K	0.09%	157
2024 Q4	$567K	Sell	10,017 -2,978	-23%	-$166K	0.08%	163
2024 Q3	$672K	Buy	12,995 +2,961	+30%	+$139K	0.1%	152
2024 Q2	$417K	Sell	10,034 -135	-1%	-$6.04K	0.07%	169
2024 Q1	$551K	Buy	10,169 +147	+1%	+$7.49K	0.1%	141
2023 Q4	$514K	Sell	10,022 -325	-3%	-$17.1K	0.11%	142
2023 Q3	$601K	Sell	10,347 -300	-3%	-$18.4K	0.15%	118
2023 Q2	$681K	Sell	10,647 -741	-7%	-$49.7K	0.16%	111
2023 Q1	$789K	Sell	11,388 -404	-3%	-$28.5K	0.2%	96
2022 Q4	$848K	Sell	11,792 -1,150	-9%	-$86.7K	0.23%	90
2022 Q3	$920K	Buy	+12,942	New	+$939K	0.29%	83

Other funds holding BMY

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Colonial Trust's BMY Position: Q2 2026 in Review

Colonial Trust reduced its Bristol-Myers Squibb (BMY) stake by 11% in Q2 2026, selling an estimated $56K and leaving 7,794 shares worth $449K. The position accounts for 0.06% of the portfolio, ranked #187.

Colonial Trust first reported a position in BMY in Q3 2022 and has held it in 16 quarters since. The position peaked at $920K in Q3 2022. 2,526 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

Colonial Trust held 7,794 shares of Bristol-Myers Squibb worth $449K as of Q2 2026.
Colonial Trust sold 975 Bristol-Myers Squibb shares in Q2 2026, an estimated $56K.
Bristol-Myers Squibb made up 0.06% of Colonial Trust's portfolio in Q2 2026, its #187 holding.
Colonial Trust first reported a position in Bristol-Myers Squibb in Q3 2022 and has held it in 16 quarters since.
Colonial Trust's Bristol-Myers Squibb position peaked at $920K in Q3 2022.
2,526 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Colonial Trust's 13F filing for Q2 2026, filed 11 Aug 2026.